We sat down with Abby Fraser, Vice President of Marketing at LARVOL, to answer some questions about the Marketing team!
LARVOL is comprised of dedicated individuals from all over the globe with an equally diverse set of skills. We call ourselves "Tigers" to remind us of the strength and speed we apply to our work. From data analysts to subject matter experts to customer success specialists and beyond, we are proud of all our Tiger Teamss.
This month, we're kicking off a new series introducing the people behind each team. We sat down with Abby Fraser, Vice President of Marketing at LARVOL, to go "behind-the-screens" and meet the LARVOL Marketing Team.
Abby: Right now, we are an all-female team, which adds a fun layer of camaraderie to our otherwise very different lives. We are also all fairly new to the LARVOL community, and we've come together very quickly as we try to stay "Fast and On a Mission."
One thing we all share is a sense of adventure, traveling the world in camper vans, on planes, trains, and everything in between. You never know where a team member will be when we get together in our VR office.
Abby: We like to think about our work in two major buckets: building the LARVOL brand and generating new leads for our sales team to engage. This includes all the traditional marketing tools from social media and digital advertising to email marketing and conferences, with the added bonus of Virtual Reality. Each member of our team specializes in one area, and we truly rely on each other to keep all those boats afloat and working towards the same goal.
Abby: Like any good Marketing team, we are all about the metrics. While I'm not going to reveal our specific numbers here, I will say we are hoping to unlock what Bruno would call a "secret door" to amplify the LARVOL story more broadly and clearly in the coming year.
Another team goal is to get a few Marketing Tigers together in person in the same place some time this year. Until then we will enjoy our Friday Tic-Tac-Ti games in VR!
Vice President, Marketing
Home Base: Nashville, Tennessee, USA
Fun Fact: Abby is currently traveling the US living and working out of a camper van with her husband and grey-haired chihuahua.
Digital Media Specialist
Home Base: Toronto, Ontario, Canada
Fun Fact: Rosalind is the captain of her league baseball team in Toronto.
Business Operations Specialist, Events Manager
Home Base: Windsor, Ontario, Canada
Fun Fact: Jane is currently traveling in the Middle East while working remotely.
Home Base: Paris, France
Fun Fact: Smriti survived a tear gas attack once and lived to tell the tale!
Social Media Specialist
Home Base: Noblesville, Indiana, USA
Fun Fact: Kylie has always been interested in weather and wanted to be a Meteorologist growing up.
Virtual Reality Intern
Home Base: Gilbert, Arizona, USA
Fun Fact: Shannon is studying Human Systems Engineering and Sociology at Arizona State University
Lead Generation Team Lead
Home Base: Karimnagar, Telangana, India
Stay Tuned: Arfia spearheads the Lead Generation team at LARVOL, an important subset of our Marketing family, and we'll be spotlighting her team in an upcoming month!
79% had reduction in disease. ORR 31%. Many responses deepen over time.
Toxicity profile was in line with prior TIL/Lifileucel data. No surprises here. Median # doses of IL-2 was 6.
Absolutely agree!… this should be available to our melanoma patients ASAP!… and paves the way for smarter cellular therapies to be designed, studied, and eventually widely disseminated
Just before I start AM clinic at @cityofhopeoc, excited to share results from #COBALT_RCC, a P1 trial of @CRISPRTX#CTX130 in #kidneycancer in the @sitcancer#PressProgram. Will present more on Thurs 5:37p at #SITC22! Thx @neerajaiims@DrBenTran@HaanenJohn#SamerSrour& co-Is! t.co/aDnhG9n92A
@montypal@cityofhopeoc@CRISPRTX@sitcancer@neerajaiims@DrBenTran@HaanenJohn@DrChoueiri@TiansterZhang@tompowles1@brian_rini@AlbigesL@Uromigos@ERPlimackMD@drenriquegrande@PGrivasMDPhD Congrats Monty! Looking forward to hearing about this exciting first-in the field study!
CAR-Ts are coming for #kidneycancer!! Congratulations @montypal and team; can’t wait to see results at #SITC22! t.co/9MrlF2yzBe
Congrats @montypal and team! Great to see CAR T therapy coming to #RCCt.co/ypRHBC89Pt
Another huge step from none other than @montypal!! CAR-Ts in #kidneycancer!Congratulations to the entire team!Looking forward to seeing the results at #SITC22! t.co/HvKeVBPyV7
@montypal you never stop to amaze me! You are brilliant & awesome! Looking forward to hearing more about this trial @sitcancer@OncoAlert@CityofHope_GU@COHMDCareers@neerajaiims@KidneyCancer@KidneyCancerDoc@NazliDizman@ZeynepZengin@LuisMezaco@crisbergerot@PauloBergerott.co/RNzOwxixQm
Primary results from the randomized Phase II RIGHT Choice trial of premenopausal patients with aggressive HR+/HER2− advanced breast cancer treated with ribociclib + endocrine therapy vs physician’s choice combination chemotherapy
Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network